Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.

Troy LK, Grainge C, Corte TJ, Williamson JP, Vallely MP, Cooper WA, Mahar A, Myers JL, Lai S, Mulyadi E, Torzillo PJ, Phillips MJ, Jo HE, Webster SE, Lin QT, Rhodes JE, Salamonsen M, Wrobel JP, Harris B, Don G, Wu PJC, Ng BJ, Oldmeadow C, Raghu G, Lau EMT; Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease alliance (COLDICE) Investigators.

Lancet Respir Med. 2019 Sep 27. pii: S2213-2600(19)30342-X. doi: 10.1016/S2213-2600(19)30342-X. [Epub ahead of print]

PMID:
31578168
2.

NR4A3 Immunohistochemistry Lacks Sensitivity for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.

Vargas AC, Maclean FM, Bonar F, Mahar A, Gill AJ.

Am J Surg Pathol. 2019 Dec;43(12):1726-1728. doi: 10.1097/PAS.0000000000001346. No abstract available.

PMID:
31414988
3.

Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre study.

Troy LK, Grainge C, Corte T, Williamson JP, Vallely MP, Cooper W, Mahar AM, Lai S, Mulyadi E, Torzillo PJ, Salamonsen M, Don G, Myers J, Raghu G, Lau EMT; COLDICE Investigator Team.

BMJ Open Respir Res. 2019 Jun 21;6(1):e000443. doi: 10.1136/bmjresp-2019-000443. eCollection 2019.

4.

Mammary-type myofibroblastoma in the head and neck region.

Luk PP, Junaid M, Mahar A, Clark JR, Gupta R.

Pathology. 2019 Aug;51(5):544-547. doi: 10.1016/j.pathol.2019.01.015. Epub 2019 Jun 17. No abstract available.

PMID:
31221433
5.

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry.

Jo HE, Corte TJ, Glaspole I, Grainge C, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Keir GJ, Cooper WA, Mahar AM, Ellis S, Macansh S, Goh NS.

BMC Pulm Med. 2019 May 3;19(1):84. doi: 10.1186/s12890-019-0846-2.

6.

Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.

Luk PP, Selinger CI, Cooper WA, Mahar A, Palme CE, O'Toole SA, Clark JR, Gupta R.

Head Neck Pathol. 2019 Sep;13(3):397-414. doi: 10.1007/s12105-018-0988-1. Epub 2018 Nov 22. Review.

7.

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.

Jo HE, Glaspole I, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Macansh S, Grainge C, Keir GJ, Hayen A, Henderson D, Klebe S, Heinze SB, Miller A, Rouse HC, Duhig E, Cooper WA, Mahar AM, Ellis S, McCormack SR, Ng B, Godbolt DB, Corte TJ.

Respirology. 2019 Apr;24(4):361-368. doi: 10.1111/resp.13427. Epub 2018 Oct 17.

8.

An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer.

Ahmadzada T, Kao S, Reid G, Boyer M, Mahar A, Cooper WA.

J Clin Med. 2018 Jun 15;7(6). pii: E153. doi: 10.3390/jcm7060153. Review.

9.

Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization.

Luk PP, Selinger CI, Mahar A, Cooper WA.

Arch Pathol Lab Med. 2018 Aug;142(8):922-928. doi: 10.5858/arpa.2017-0502-RA. Epub 2018 Jun 14. Review.

PMID:
29902067
10.

FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center.

Vargas AC, Selinger C, Satgunaseelan L, Cooper WA, Gupta R, Stalley P, Brown W, Soper J, Schatz J, Boyle R, Thomas DM, Tattersall MHN, Bhadri V, Maclean F, Bonar SF, Scolyer RA, Karim RZ, McCarthy SW, Mahar A, O'Toole SA.

Asia Pac J Clin Oncol. 2019 Feb;15(1):38-47. doi: 10.1111/ajco.12980. Epub 2018 May 28.

PMID:
29806089
11.

Fluorescent In Situ Hybridization in Surgical Pathology Practice.

Gupta R, Cooper WA, Selinger C, Mahar A, Anderson L, Buckland ME, O'Toole SA.

Adv Anat Pathol. 2018 Jul;25(4):223-237. doi: 10.1097/PAP.0000000000000194. Review.

PMID:
29727321
12.

Pigmented Paget's disease of the nipple mistaken for melanoma in situ: a diagnostic pitfall for the unwary.

Solinas A, Mahar A, Cooper WA, Thompson JF, Spillane AJ, Scolyer RA.

Pathology. 2018 Apr;50(3):364-367. doi: 10.1016/j.pathol.2017.09.018. Epub 2018 Mar 1. No abstract available.

PMID:
29490872
13.

Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary.

Jo HE, Prasad JD, Troy LK, Mahar A, Bleasel J, Ellis SJ, Chambers DC, Holland AE, Lake FR, Keir G, Goh NS, Wilsher M, de Boer S, Moodley Y, Grainge C, Whitford HM, Chapman SA, Reynolds PN, Beatson D, Jones LJ, Hopkins P, Allan HM, Glaspole I, Corte TJ.

Med J Aust. 2018 Feb 5;208(2):82-88.

PMID:
29385965
14.

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.

Jo HE, Glaspole I, Moodley Y, Chapman S, Ellis S, Goh N, Hopkins P, Keir G, Mahar A, Cooper W, Reynolds P, Haydn Walters E, Zappala C, Grainge C, Allan H, Macansh S, Corte TJ.

BMC Pulm Med. 2018 Jan 25;18(1):19. doi: 10.1186/s12890-018-0575-y.

15.

The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53.

Szczepny A, Carey K, McKenzie L, Jayasekara WSN, Rossello F, Gonzalez-Rajal A, McCaw AS, Popovski D, Wang D, Sadler AJ, Mahar A, Russell PA, Wright G, McCloy RA, Garama DJ, Gough DJ, Baylin SB, Burgess A, Cain JE, Watkins DN.

Oncogene. 2018 Apr;37(14):1939-1948. doi: 10.1038/s41388-017-0022-1. Epub 2018 Jan 25.

16.

Correction: Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis (doi: 10.1242/dmm.030114).

Tjin G, White ES, Faiz A, Sicard D, Tschumperlin DJ, Mahar A, Kable EPW, Burgess JK.

Dis Model Mech. 2017 Dec 19;10(12):1545. doi: 10.1242/dmm.033191. No abstract available.

17.

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.

Tjin G, White ES, Faiz A, Sicard D, Tschumperlin DJ, Mahar A, Kable EPW, Burgess JK.

Dis Model Mech. 2017 Nov 1;10(11):1301-1312. doi: 10.1242/dmm.030114. Erratum in: Dis Model Mech. 2017 Dec 19;10 (12 ):1545.

18.

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.

Prasad JD, Mahar A, Bleasel J, Ellis SJ, Chambers DC, Lake F, Hopkins PMA, Corte TJ, Allan H, Glaspole IN.

Respirology. 2017 Oct;22(7):1459-1472. doi: 10.1111/resp.13163. Epub 2017 Sep 10.

19.

Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis.

Glaspole IN, Watson AL, Allan H, Chapman S, Cooper WA, Corte TJ, Ellis S, Grainge C, Goh N, Hopkins P, Keir G, Macansh S, Mahar A, Moodley Y, Reynolds PN, Ryerson CJ, Walters EH, Zappala CJ, Holland AE.

Eur Respir J. 2017 Aug 17;50(2). pii: 1700168. doi: 10.1183/13993003.00168-2017. Print 2017 Aug. No abstract available.

20.

Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non-Small Cell Lung Cancer.

Cooper WA, Russell PA, Cherian M, Duhig EE, Godbolt D, Jessup PJ, Khoo C, Leslie C, Mahar A, Moffat DF, Sivasubramaniam V, Faure C, Reznichenko A, Grattan A, Fox SB.

Clin Cancer Res. 2017 Aug 15;23(16):4569-4577. doi: 10.1158/1078-0432.CCR-17-0151. Epub 2017 Apr 18.

Supplemental Content

Loading ...
Support Center